TIGECYCLINE

Generic: TIGECYCLINE

Eugia US LLCManufacturer
INTRAVENOUSRoute
TIGECYCLINEActive Substance
2019-06-11Original Approval

TIGECYCLINE is FDA application ANDA206335, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
638 reports
2
OFF LABEL USE
549 reports
3
NAUSEA
302 reports
4
DRUG RESISTANCE
213 reports
5
SEPSIS
207 reports
6
VOMITING
205 reports
7
SEPTIC SHOCK
193 reports
8
THROMBOCYTOPENIA
193 reports
9
PATHOGEN RESISTANCE
172 reports
10
PRODUCT USE IN UNAPPROVED INDICATION
168 reports